Skip to main content

Table 2 Demographic and clinical data of referred patients with and without residual tumour at re-excision

From: Is revisional surgery mandatory when an unexpected sarcoma diagnosis is made following primary surgery?

 

Referred patients without residual tumour (n=33)

Referred patients with residual tumour (n=38)

p-value

Statistical test

Demographics

   

Students t test

 Male

57.8%

49.0%

0.391

 Female

42.2%

51.0%

 Under 50 years of age

75.6%

58.8%

0.083

 50 years of age and older

24.4%

41.2%

 Median age

57.24

54.78

0.523

Clinical data

    

FNCLCC grade

   

Chi2 test

 Low

29.3%

18.2%

0.483

 Intermediate

36.6%

43.2%

 High

34.1%

38.6%

Tumour size

   

Chi2 test

 Size ≤ 5 cm (T1)

48.8%

54.5%

0.595

 Size > 5 cm (T2)

51.2%

45.5%

Tumour location with reference to fascia

   

Chi2 test

 Superficial (Ta)

39.0%

29.5%

0.357

 Deep (Tb)

61.0%

70.5%

NCCN stage

   

Chi2 test

 IA

17.1%

9.1%

0.146

 IB

17.1%

11.4%

 IIA

34.1%

47.7%

 IIB

9.8%

15.9%

 III

22.0%

9.1%

 IV

0.0%

6.8%

Histopathological diagnosis

   

Chi2 test

 Liposarcoma

37.8%

27.5%

0.861

 Leiomyosarcoma

6.7%

7.8%

 Rhabdomyosarcoma

2.2%

3.9%

 Synovial sarcoma

6.7%

7.8%

 Malignant fibrous histiocytoma

22.2%

15.7%

 Fibrosarcoma

11.1%

11.8%

 Other

13.30%

25.50%

Location

   

Chi2 test

 Upper extremity

17.8%

41.2%

0.001

 Lower extremity

62.2%

33.3%

 Head and neck

8.9%

0.0%

 Trunk

11.1%

25.5%